> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Flagyl Not Withdrawn Due to Safety/Efficacy
- URL: https://www.fdaweb.com/flagyl-not-withdrawn-due-to-safety-efficacy/
- Published: 2024-09-04T12:00:00.000Z
- Updated: 2026-09-14T14:40:22.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157705

*Federal Register* notice: FDA has determined that Pfizer’s Flagyl (metronidazole) tablets, 250mg and 500mg, were not withdrawn due to safety or effectiveness reasons. The determination permits the agency to approve ANDAs that reference the product as long as they meet relevant legal and regulatory requirements. The product is indicated for treating symptomatic and asymptomatic *Trichomoniasis*, treatment of asymptomatic sexual partners, and anaerobic bacterial infections, among other infections. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-09-04/pdf/2024-19721.pdf?ref=fdaweb.com).